Search Results - "Meshkova, Yulia V."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2
  3. 3

    Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies by Pon'kina, Darya A, Kuranov, Sergey O, Marenina, Mariya K, Meshkova, Yulia V, Zhukova, Nataliya A, Khvostov, Mikhail V, Luzina, Olga A, Tolstikova, Tatiana G, Salakhutdinov, Nariman F

    Published in Pharmaceutics (01-06-2023)
    “…Type 2 diabetes mellitus (T2DM) is one of the most common chronic diseases worldwide. Several classes of hypoglycemic drugs are used to treat it, but various…”
    Get full text
    Journal Article
  4. 4

    9-N-n-alkyl Berberine Derivatives: Hypoglycemic Activity Evaluation by Khvostov, Mikhail V, Gladkova, Elizaveta D, Borisov, Sergey A, Fedotova, Marina S, Zhukova, Nataliya A, Marenina, Mariya K, Meshkova, Yulia V, Valutsa, Nicolae, Luzina, Olga A, Tolstikova, Tatiana G, Salakhutdinov, Nariman F

    Published in Pharmaceutics (22-12-2022)
    “…Several novel 9-N-n-alkyl derivatives of berberine (C5, C7, C10, C12) were synthesized. They were analyzed in vitro and in vivo for their hypoglycemic…”
    Get full text
    Journal Article
  5. 5

    Conjugates of Lupane Triterpenoids with Arylpyrimidines: Synthesis and Anti-inflammatory Activity by Semenova, Maria D., Popov, Sergey A., Sorokina, Irina V., Meshkova, Yulia V., Baev, Dmitry S., Tolstikova, Tatyana G., Shults, Elvira E.

    Published in Steroids (01-08-2022)
    “…[Display omitted] •An approach to lupane triterpenoid alkynyl ketones was proposed for the first time.•Fifteen betulonic acid amide-arylpyrimidine conjugated…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Synthesis and Evaluation of Hypoglycemic Activity of Structural Isomers of propanoic Acid Bearing an Aminobornyl Moiety by Kuranov, Sergey O, Pon`kina, Darya A, Meshkova, Yulia V, Marenina, Mariya K, Khvostov, Mikhail V, Luzina, Olga A, Tolstikova, Tatiana G, Salakhutdinov, Nariman F

    “…Free fatty acid receptor-1 (FFAR1) agonists are promising candidates for therapy of type 2 diabetes because of their ability to normalize blood sugar levels…”
    Get full text
    Journal Article